Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국
월요일, 8월 31

Inspire Medical Systems Inc

INSPNYSE
Trade with Public
Trade with Public
$62.99
1.552.52%
가까이에: Aug 31, 5:00 PM EST
$63.50
0.510.81%
시간외: 4:06 PM EST
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교옵션주식 보고서

Inspire Medical Systems Financials

Inspire Medical Systems (INSP) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Inspire Medical Systems Analysts Raise Their Forecasts Following Strong Q2 Results

INSPI beats expectations, raises FY26 guidance. Analysts raise price targets to $59 & $60. Stock jumps 14.6% in pre-market trading. #INSP
Avi Kapoor

PRO
Inspire Medical Systems Lowers FY2026 GAAP EPS Guidance from $0.07-$0.62 to $(0.42)-$0.17 vs $0.90 Est

Inspire Medical Systems (NYSE:INSP) lowers FY2026 GAAP EPS guidance from $0.07-$0.62 to $(0.42)-$0.17 vs $0.90 analyst estimate..
Benzinga Newsdesk

PRO
Inspire Medical Systems Raises FY2026 Adj EPS Guidance from $0.75-$1.25 to $1.05-$1.45 vs $0.38 Est; Raises FY2026 Sales Guidance from $825.000M-$875.000M to $835.000M-$875.000M vs $843.387M Est

Inspire Medical Systems (NYSE:INSP) raises FY2026 Adj EPS guidance from $0.75-$1.25 to $1.05-$1.45 vs $0.38 analyst estimate. Raises FY2026 sales outlook from $825.000 million-$875.000 million to $835.000
Benzinga Newsdesk

PRO
Inspire Medical Systems Q2 Adj. EPS $0.14 Beats $(0.27) Estimate, Sales $200.581M Beat $194.671M Estimate

Inspire Medical Systems (NYSE:INSP) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $(0.27) by 151.85 percent. This is a 58.82 percent decrease over earnings of $0.34 per
Benzinga Newsdesk

Stock Market Today: Dow, S&P 500, Nasdaq Futures Rise As Traders Monitor US-Iran Ceasefire— Duolingo, Pinterest, AMD In Focus (UPDATED)

(Editor’s note: The future prices of benchmark tracking ETFs, and the headline were updated in the story.)
Rishabh Mishra

PRO
Inspire Medical Systems Lowers FY2026 GAAP EPS Guidance from $1.23-$1.81 to $0.07-$0.62 vs $1.63 Est

Inspire Medical Systems (NYSE:INSP) lowers FY2026 GAAP EPS guidance from $1.23-$1.81 to $0.07-$0.62 vs $1.63 analyst estimate..
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

Benzinga

Benzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved